Prostate cancer Board decisions

The Veteran's exposure to contaminated water at Camp Lejeune is considered as likely as not the cause of his prostate cancer, which was diagnosed years after service. The Board granted service connection for prostate cancer.

The Board denied the Veteran's claim for a total disability rating based on individual unemployability (TDIU) prior to April 3, 2017 and from August 2, 2017 due to insufficient evidence showing that his service-connected disabilities rendered him unable to secure or follow substantially gainful employment.

The Board has remanded the issue of service connection for prostate cancer due to in-service radiation exposure. The prior decision failed to explain how it applied the presumption of regularity to film badges, and the Veteran's statements about his duties as a dental technician are now considered.

The Board denied the claim for service connection for the cause of the Veteran's death, finding that there was no evidence to support a link between any service-connected condition and the Veteran's stroke.

The Board has determined that further development is needed for the Veteran's prostate cancer, type II diabetes mellitus (DMII), and residuals of a cerebral infarction claims due to potential recurrence or new evidence. The TDIU claim is also remanded as it is inextricably intertwined with these issues.

The Board has determined that the Veteran's prostate cancer is service-connected due to exposure to herbicide agents in Thailand, and affords him the benefit of the doubt.

The Veteran's prostate cancer is granted service connection due to exposure to herbicide agents during his service in Thailand.

The Veteran's service-connected residuals of postoperative prostate cancer were restored to a 100% disability rating, effective May 1, 2016. SMC at the housebound rate was also restored.

The Veteran's appeal for higher staged ratings and increased disability rating for prostate cancer residuals has been dismissed due to the death of the appellant.

The Board has decided to remand the Veteran's claims for sleep apnea and prostate cancer, as they may be related to service. The VA will need to obtain relevant medical records and schedule the Veteran for examinations to determine if his conditions are linked to his time in service.

The Board has decided to remand the claims for service connection for prostate and bladder cancer, as well as colon and stomach cancers with metastasis. The VA will need to obtain additional service records and TDY orders to determine if the Veteran was exposed to herbicides during his service.

The Board denied the Veteran's claim for an increased rating for prostate cancer residuals, finding that a 40 percent rating was appropriate from January 1, 2016 through September 29, 2019. The Veteran’s condition did not warrant a higher rating based on urinary leakage or renal dysfunction.

The Veteran's prostate cancer was not shown in service or for many years thereafter, and is not otherwise etiologically related to active duty service.,There is no evidence of bladder cancer prior to the Veteran's death.

The Board has remanded the Veteran's claims for prostate cancer, small intestine cancer, large intestine cancer, nose cancer (claimed as radical flap), skin cancer, and stomach cancer due to exposure to contaminated water at Camp Lejeune. The claims are being remanded for an examination to determine if these cancers are related to service.

The Veteran's prostate cancer residuals were rated from November 1, 2012 to December 21, 2014 at a 10% rating and since then at a 20% rating. Bilateral hearing loss was not compensable. The issues of service connection for lower extremity neuropathy and increased ratings for prostate cancer residuals and bilateral hearing loss were remanded.

The Board has determined that a remand is necessary to determine if the Veteran's left breast lobular cancer is related to his service-connected prostate cancer, and whether it was caused by exposure to herbicide agents. The examination should assess if there is any aggravation of the left breast lobular cancer due to the service-connected prostate cancer.

The Board has remanded the Veteran's claims for service connection for CLL and prostate cancer, both of which are currently pending. The case will be reviewed again with consideration of new evidence submitted by the Veteran.

The Board has denied the Veteran's claim for service connection for prostate cancer, finding no evidence of a nexus between his current condition and military service.

The Board has granted service connection for prostate cancer, diabetes mellitus type II (DM), and erectile dysfunction as secondary to prostate cancer due to herbicide exposure during service at the Royal Thai Air Force Base in Thailand.

The Veteran's prostate cancer disability rating was reduced from 100% to 20%, effective May 1, 2018. The RO also denied his claim for an increased rating for residuals of prostate cancer and termination of SMC based on housebound status.